[HTML][HTML] 2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants

J Douxfils, DM Adcock, SM Bates… - Thrombosis and …, 2021 - thieme-connect.com
In 2018, the International Council for Standardization in Haematology (ICSH) published a
consensus document providing guidance for laboratories on measuring direct oral …

[HTML][HTML] Estrogen actions in placental vascular morphogenesis and spiral artery remodeling: A comparative view between Humans and Mice

M Rusidzé, A Gargaros, C Fébrissy, C Dubucs, A Weyl… - Cells, 2023 - mdpi.com
Estrogens, mainly 17β-estradiol (E2), play a critical role in reproductive organogenesis,
ovulation, and fertility via estrogen receptors. E2 is also a well-known regulator of utero …

Low thrombin generation in users of a contraceptive containing estetrol and drospirenone

L Morimont, M Jost, U Gaspard… - The Journal of …, 2023 - academic.oup.com
Objective To compare the impact on thrombin generation of the new combined oral
contraceptive containing 15 mg estetrol and 3 mg drospirenone with ethinylestradiol (30 or …

[HTML][HTML] Estetrol: from preclinical to Clinical Pharmacology and advances in the understanding of the molecular mechanism of action

C Gérard, JM Foidart - Drugs in R&D, 2023 - Springer
Estetrol (E4) is the most recently described natural estrogen. It is produced by the human
fetal liver during pregnancy and its physiological function remains unclear. E4 is the …

A novel estetrol-containing combined oral contraceptive: European expert panel review

K Gemzell-Danielsson, A Cagnacci… - … European Journal of …, 2022 - Taylor & Francis
Purpose Despite considerable advances in recently developed combined oral
contraceptives (COCs), resulting in lower rates of adverse events while maintaining …

Oral contraceptive pills and hypertension: a review of current evidence and recommendations

NA Cameron, CA Blyler, NA Bello - Hypertension, 2023 - Am Heart Assoc
Oral contraceptive pills (OCPs) have been used as effective and popular forms of
contraception since the middle of the last century. By 2019, over 150 million reproductive …

Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women

J Douxfils, U Gaspard, M Taziaux, M Jost, C Bouvy… - …, 2023 - Taylor & Francis
Objective This study aimed to determine the effects of estetrol (E4) on hemostasis, lipids,
carbohydrate metabolism and bone turnover in postmenopausal women. Methods This …

Biosynthesis of estetrol in human pregnancy: Potential pathways

FZ Stanczyk, DF Archer - The Journal of Steroid Biochemistry and …, 2023 - Elsevier
Estetrol (E 4) has emerged as a novel and highly promising estrogen for therapeutic use. E 4
is a weak natural estrogen produced only in pregnancy. Because of its novelty, there is …

Experts' view on the role of oestrogens in combined oral contraceptives: emphasis on oestetrol (E4)

MD Creinin, A Cagnacci, RZ Spaczyński… - Frontiers in global …, 2024 - frontiersin.org
Introduction The evolution of contraception has been crucial for public health and
reproductive well-being. Over the past 60 years, combined oral contraceptives (COCs) have …

[HTML][HTML] Bleeding patterns of oral contraceptives with a cyclic dosing regimen: an overview

DF Archer, D Mansour, JM Foidart - Journal of Clinical Medicine, 2022 - mdpi.com
Bleeding irregularities are one of the major reasons for discontinuation of oral
contraceptives (OCs), and therefore clinicians need to set expectations during consultations …